- Home
- SYTA vs PALI Comparison
SYTA vs PALI Comparison
Compare SYTA & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- PALI
- Stock Information
- Founded
- SYTA N/A
- PALI 1996
- Country
- SYTA Canada
- PALI United States
- Employees
- SYTA N/A
- PALI N/A
- Industry
- SYTA Telecommunications Equipment
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SYTA Telecommunications
- PALI Health Care
- Exchange
- SYTA Nasdaq
- PALI Nasdaq
- Market Cap
- SYTA 3.3M
- PALI 3.5M
- IPO Year
- SYTA 2020
- PALI N/A
- Fundamental
- Price
- SYTA $0.75
- PALI $1.75
- Analyst Decision
- SYTA
- PALI Strong Buy
- Analyst Count
- SYTA 0
- PALI 2
- Target Price
- SYTA N/A
- PALI $23.00
- AVG Volume (30 Days)
- SYTA 2.0M
- PALI 3.7M
- Earning Date
- SYTA 11-14-2024
- PALI 11-12-2024
- Dividend Yield
- SYTA N/A
- PALI N/A
- EPS Growth
- SYTA N/A
- PALI N/A
- EPS
- SYTA N/A
- PALI N/A
- Revenue
- SYTA $11,988,979.00
- PALI N/A
- Revenue This Year
- SYTA $75.92
- PALI N/A
- Revenue Next Year
- SYTA $19.72
- PALI N/A
- P/E Ratio
- SYTA N/A
- PALI N/A
- Revenue Growth
- SYTA 41.59
- PALI N/A
- 52 Week Low
- SYTA $0.62
- PALI $1.38
- 52 Week High
- SYTA $90.90
- PALI $22.35
- Technical
- Relative Strength Index (RSI)
- SYTA 35.57
- PALI 40.97
- Support Level
- SYTA $0.62
- PALI $1.59
- Resistance Level
- SYTA $0.94
- PALI $2.20
- Average True Range (ATR)
- SYTA 0.10
- PALI 0.39
- MACD
- SYTA 0.00
- PALI 0.02
- Stochastic Oscillator
- SYTA 15.94
- PALI 19.27
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.